Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 605 | 2,202 | 47 | 45 | 44 |
| Gross Profit | 605 | 2,202 | 47 | 45 | 44 |
| Operating Expenses | 221,485 | 158,453 | 98,436 | 99,165 | 124,544 |
| Operating Income | -220,880 | -156,251 | -98,389 | -99,120 | -124,500 |
| Interest Expense | 9,074 | 5,920 | 433 | 618 | 66 |
| Other Income | 3,921 | 1,908 | 2,093 | 2,822 | 3,185 |
| Pre-tax Income | -226,033 | -160,263 | -96,729 | -96,916 | -121,381 |
| Income Tax | -1,846 | -105 | -503 | -493 | -572 |
| Net Income Continuous | -224,187 | -160,158 | -96,226 | -96,423 | -120,809 |
| Minority Interests | -2,336 | -2,381 | N/A | N/A | N/A |
| Net Income | $-221,851 | $-157,777 | $-96,226 | $-96,423 | $-120,809 |
| EPS Basic Total Ops | -0.59 | -0.43 | -1.22 | -1.20 | -1.47 |
| EPS Basic Continuous Ops | -0.59 | -0.44 | -1.22 | -1.20 | -1.47 |
| EPS Diluted Total Ops | -0.59 | -0.43 | -1.22 | -1.20 | -1.47 |
| EPS Diluted Continuous Ops | -0.59 | -0.44 | -1.22 | -1.20 | -1.47 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.70 | N/A | N/A | N/A |
| EBITDA(a) | $-207,347 | $-142,209 | $-88,371 | $-91,957 | $-118,711 |